| SVOBODA, Marek, Ondřej SLABÝ, Renata HÉŽOVÁ, Pavel FABIAN, Ilona KOCÁKOVÁ, Barbora ONDROVÁ and Rostislav VYZULA. MicroRNA profiling in predictive oncology of colorectal cancer. In RNAi & miRNA World Congess, Epigenetics World Congress, Genomics Automation Congress, Boston. 2010. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{984865,
author = {Svoboda, Marek and Slabý, Ondřej and Héžová, Renata and Fabian, Pavel and Kocáková, Ilona and Ondrová, Barbora and Vyzula, Rostislav},
booktitle = {RNAi & miRNA World Congess, Epigenetics World Congress, Genomics Automation Congress, Boston},
keywords = {microRNAs; colorectal cancer; fluoropyrimidine-based chemoradiotherapy},
language = {eng},
title = {MicroRNA profiling in predictive oncology of colorectal cancer.},
year = {2010}
}
TY - CONF
ID - 984865
AU - Svoboda, Marek - Slabý, Ondřej - Héžová, Renata - Fabian, Pavel - Kocáková, Ilona - Ondrová, Barbora - Vyzula, Rostislav
PY - 2010
TI - MicroRNA profiling in predictive oncology of colorectal cancer.
KW - microRNAs
KW - colorectal cancer
KW - fluoropyrimidine-based chemoradiotherapy
N2 - Fluoropyrimidine-base chemoradiotherapy before total mesorectal excision (TME) is currently the gold standard treatment for stage II and III rectal cancer patients. Pathological complete response is related with a longer relaps and overall survival. On the other hand, patients with a primary resistant tumors could be spared exposure to chemotherapy and radiation that are associated with substantial adverse effects and costs, and surgery could be schduled without delay. We have used microRNA profilling to identify in our series responders and non responders to preoperative treatment.
ER -
SVOBODA, Marek, Ondřej SLABÝ, Renata HÉŽOVÁ, Pavel FABIAN, Ilona KOCÁKOVÁ, Barbora ONDROVÁ and Rostislav VYZULA. MicroRNA profiling in predictive oncology of colorectal cancer. In \textit{RNAi \&{} miRNA World Congess, Epigenetics World Congress, Genomics Automation Congress, Boston}. 2010.
|
